Laboratorios Richmond S.A.C.I.F. (RICH.BA)
ARS 1735.0
(-1.98%)
ARS 1735.0
(-1.98%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -2.5 Billion | -13.34 Billion | 7.27 Billion | -181.33 Million | 88.89 Million |
| Net Income | -10.85 Billion | 508.94 Million | 1.15 Billion | 733.93 Million | 116.44 Million |
| Depreciation & Amortization | 2.33 Billion | 2.27 Billion | 673.19 Million | 255.12 Million | 136.85 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | 22.29 Billion | -13.65 Billion | 3.33 Billion | -1.6 Billion | -236.03 Million |
| Other non-cash items | -14.71 Billion | -5.56 Billion | 27.92 Million | -166.17 Million | 71.63 Million |
| Investing Cash Flow | -12.55 Billion | -23.18 Billion | -11.77 Billion | -1.06 Billion | -497.11 Million |
| Investments in PPE | -12.51 Billion | -23.41 Billion | -11.54 Billion | -917.95 Million | -278.13 Million |
| Acquisitions | -205.19 Million | -125.27 Million | -657.42 Thousand | -65.89 Million | -47.97 Million |
| Investment purchases | -455.22 Million | - | - | - | -1.63 Million |
| Sales/Maturities of investments | - | - | - | - | 2.11 Million |
| Other Investing Activities | -45 Million | - | - | - | - |
| Financing Cash Flow | 9.24 Billion | 4.07 Billion | 17.79 Billion | 1.7 Billion | 22.32 Million |
| Debt repayment | -9.24 Billion | -5.66 Billion | -17.9 Billion | -1.7 Billion | -22.32 Million |
| Dividends payments | - | -681.69 Million | -116.61 Million | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - |
| Other Financing Activities | - | -902.62 Million | - | - | - |
| Accounts receivables | -5.48 Billion | - | - | - | -1.18 Billion |
| Accounts payables | 25.96 Billion | - | - | - | 861.89 Million |
| Inventory | 271.48 Million | 7.5 Billion | -3.07 Billion | -588.38 Million | -117.77 Million |
| Other working capital | 27.5 Billion | - | - | - | 208.01 Million |
| Cash at beginning of period | 8.37 Billion | 44.64 Billion | 1.55 Billion | 449.75 Million | 501.11 Million |
| Cash at end of period | 823.02 Million | 8.37 Billion | 14.33 Billion | 796.92 Million | 217.14 Million |
| Capital Expenditure | -12.51 Billion | -23.41 Billion | -11.54 Billion | -917.95 Million | -278.13 Million |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | -7.55 Billion | -36.26 Billion | 12.78 Billion | 347.17 Million | -283.97 Million |
| Free Cash Flow | -15.02 Billion | -36.76 Billion | -4.27 Billion | -1.09 Billion | -189.24 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 2.95 Billion | 6.87 Billion | -10.85 Billion | -7.61 Billion | -2.35 Billion | -1.17 Billion |
| Depreciation & Amortization | 953.46 Million | 818.65 Million | 2.33 Billion | 1.25 Billion | 536.53 Million | -321.26 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -3.31 Billion | -4.21 Billion | 22.29 Billion | 19.56 Billion | 1.87 Billion | 740.75 Million |
| Other non-cash items | 56.01 Million | -9.07 Billion | -14.71 Billion | -10.6 Billion | -2.34 Billion | 1.16 Billion |
| Investing Cash Flow | 1.17 Billion | -1.17 Billion | -12.55 Billion | -7.16 Billion | -2.27 Billion | 1.7 Billion |
| Investments in PPE | -1.21 Billion | -1.38 Billion | -12.51 Billion | -7.34 Billion | -2.36 Billion | -1.78 Billion |
| Acquisitions | - | -215 Million | -205.19 Million | -79.34 Million | - | - |
| Investment purchases | -67.95 Million | - | - | - | - | - |
| Sales/Maturities of investments | -430.63 Million | - | - | - | - | - |
| Other Investing Activities | 1.17 Billion | - | -45 Million | - | - | - |
| Financing Cash Flow | 1.92 Billion | 2.65 Billion | 9.24 Billion | 4.56 Billion | 2.93 Billion | 2.59 Billion |
| Debt repayment | -1.92 Billion | -2.65 Billion | -9.24 Billion | -4.56 Billion | -2.93 Billion | -2.59 Billion |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | -2.96 Billion | - | - | - | - | - |
| Accounts payables | -3.18 Billion | - | - | - | - | - |
| Inventory | 2.49 Billion | 1.88 Billion | 271.48 Million | -1.35 Billion | 807.26 Million | -907.76 Million |
| Other working capital | 338.89 Million | - | - | - | - | - |
| Cash at beginning of period | 2.13 Billion | 1.24 Billion | 8.37 Billion | 613.89 Million | 1.29 Billion | 6.01 Billion |
| Cash at end of period | 38.48 Million | 2.13 Billion | 823.02 Million | 823.02 Million | 613.89 Million | 1.29 Billion |
| Capital Expenditure | -1.21 Billion | -1.38 Billion | -12.51 Billion | -7.34 Billion | -2.36 Billion | -1.78 Billion |
| Effect of forex changes on cash | - | -234.32 Million | - | - | - | - |
| Net cash flow / Change in cash | -2.09 Billion | 887.51 Million | -7.55 Billion | 209.12 Million | -678.13 Million | -4.72 Billion |
| Free Cash Flow | -555.04 Million | -1.74 Billion | -15.02 Billion | -6.55 Billion | -4.67 Billion | -2.43 Billion |
VARO
5202
1108
199430
XTM
TG6